Disclosure Of Earnings Per Share [Text Block]

Ascelia Pharma - Filing #701899

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of earnings per share [text block]
Adjustments to reconcile profit (loss) to numerator used in calculating earnings per share [abstract]
Profit (loss), attributable to owners of parent
125 903 SEK
98 697 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.